Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection

scientific article published on 25 April 2005

Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TRIM.2005.03.014
P698PubMed publication ID15935302

P50authorIlja StrizQ43466592
P2093author name stringStefan Vitko
Antonij Slavcev
Jelena Skibová
Alena Lodererová
Eva Honsová
Helena Sajdlová
Jiri Lácha
P2860cites workTNF ligands and receptors in autoimmunity: an updateQ30743828
Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejectionQ33186082
Anti-HLA antibodies after solid organ transplantationQ33856062
Humoral rejection in kidney transplantation: new concepts in diagnosis and treatmentQ34977911
Humoral theory of transplantationQ35142603
Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants.Q40769068
Outcome of kidney transplants in patients known to be flow cytometry crossmatch positiveQ47624655
HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevanceQ47913818
Predicting kidney graft failure by HLA antibodies: a prospective trial.Q51038562
Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.Q54013696
Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survivalQ73246916
Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1Q73276645
Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30Q74211807
CD30: expression and function in health and diseaseQ77593448
Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30Q79208821
Pathology and the allo-immune responseQ79312276
P433issue2
P304page(s)117-121
P577publication date2005-04-25
P1433published inTransplant ImmunologyQ15758510
P1476titleSoluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection
P478volume14

Reverse relations

cites work (P2860)
Q46095776Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy.
Q83061041Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA
Q79781854Evaluation of pre- and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection
Q37196119Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival
Q81962549HLA class I antibodies in patients awaiting kidney transplantation and the association with renal graft survival
Q80309091Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement
Q41037053Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival
Q80275681Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection
Q85224322Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: a single center experience from China
Q86779666Post-transplant soluble CD30 levels are associated with early subclinical rejection in kidney transplantation
Q43791140Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection
Q45209562Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform
Q83344990Prediction of acute renal allograft rejection in early post-transplantation period by soluble CD30
Q42987413Soluble CD30 and Cd27 levels in patients undergoing HLA antibody-incompatible renal transplantation.
Q43466537Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft
Q80512157Soluble CD30 in patients with antibody-mediated rejection of the kidney allograft
Q91636280Soluble CD30, the Immune Response, and Acute Rejection in Human Kidney Transplantation: A Systematic Review and Meta-Analysis
Q43274504TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
Q37607455The immunological monitoring of kidney and liver transplants in adult and pediatric recipients

Search more.